Kunkel Lori Anne - Insider Non-Derivative Transactions at Oric Pharmaceuticals, Inc. (ORIC) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Dec 8, 2025, Kunkel Lori Anne's relationship to Oric Pharmaceuticals, Inc. (ORIC) is Director, and currently has 84,200 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ORIC insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Kunkel Lori Anne - Insider Non-Derivative Transactions of ORIC Common Stock
Kunkel Lori Anne - Insider Non-Derivative Transactions at ORIC
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 9, 2025 | M -- (Common Stock) | 10000 | 7.9 | 84200 |
| Dec 5, 2025 | M -- (Common Stock) | 5534 | 3.75 | 74200 |
| Mar 4, 2025 | M -- (Common Stock) | 27666 | 3.75 | 48166 |
| Mar 4, 2025 | M -- (Common Stock) | 20500 | 6.33 | 68666 |
| Jun 4, 2024 | M -- (Common Stock) | 20500 | 3.75 | 20500 |